Since its establishment in 2012, the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics has become a driving force behind advanced cancer and biomedical imaging research at the Weizmann Institute of Science and a catalyst for original research projects in these fields.
The Institute supports laboratory research, equipment acquisition, and scientific exchanges. Promoting collaborative projects between experts in both bioimaging and genomics, the Institute helps Weizmann scientists reach their goal: to elucidate the complex mechanisms of cancer.
Director
Prof. Neta Regev-Rudzki
Prof. Neta Regev-Rudzki, from the Department of Biomolecular Sciences at the Weizmann Institute of Science in Israel, leads a lab dedicated to studying the biology of Plasmodium falciparum-the parasite responsible for the most severe form of malaria.
Prof. Regev-Rudzki earned her BSc in Chemistry and MSc in Biochemistry and Genetics (2002) from the Hebrew University of Jerusalem. She completed her PhD in 2009 at the Hadassah Medical School, focusing on mitochondrial transport in a yeast model. Following postdoctoral training in malaria, at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, she established her lab in 2015.
Her groundbreaking research focuses on the communication mechanisms of the malaria parasite, particularly through the secretion of extracellular vesicles (EVs). Her lab investigates the roles of EV cargo components, including proteins, RNA, and DNA. By exploring these cellular communication mechanisms, her research has revealed how the parasite interacts with various host systems, providing insights that could open new therapeutic avenues in the battle against malaria.